Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000

Sarah Schimansky; Samantha Lang; Rhona Beynon; Christopher Penfold; Amy Davies; Andrea Waylen; Steve Thomas; Miranda Pring; Michael Pawlita; Tim Waterboer; Andy Ness

doi:10.1002/hed.25543

Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000

Sarah Schimansky^*, Samantha Lang, Rhona Beynon, Christopher Penfold, Amy Davies, Andrea Waylen, Steve Thomas, Miranda Pring, Michael Pawlita, Tim Waterboer, Andy Ness

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

34 Citations (Scopus)

206 Downloads (Pure)

Abstract

BACKGROUND: People with head and neck cancer have higher comorbidity levels but it remains unclear if pretreatment comorbidity is an independent prognosticator in head and neck cancer.

METHODS: Survival analyses were performed using data from participants in a UK multicentre cohort study with cancers of the oral cavity (n = 668), oropharynx (n = 1074), and larynx (n = 530). Survival analyses were incrementally adjusted for age, sex, marital status, income, education, stage, alcohol, and smoking.

RESULTS: After adjusting for demographic, clinical, and behavioral confounders, higher baseline comorbidity was associated with reduced overall survival (mild comorbidity HR = 1.4, 95% CI = 1.1, 1.7; moderate comorbidity HR = 1.7, 95% CI = 1.3, 2.2; severe comorbidity HR = 2.8, 95% CI = 1.9, 4.; P-trend<.001).

CONCLUSIONS: Our findings suggest that comorbidity is an independent prognosticator for overall survival in head and neck cancer. Comorbid illnesses should be considered in the assessment and treatment planning of people with head and neck cancer.

Original language	English
Pages (from-to)	1053-1062
Number of pages	10
Journal	Head and Neck
Volume	41
Issue number	4
Early online date	14 Dec 2018
DOIs	https://doi.org/10.1002/hed.25543
Publication status	Published - 1 Apr 2019

Research Groups and Themes

ICEP

Keywords

comorbidity
ACE 27
survival
head and neck cancer
human papillomavirus

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/hed.25543

Full-text PDF (accepted author manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Wiley at https://doi.org/10.1002/hed.25543 . Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 874 KB
Supplementary information PDF Tables and FiguresAccepted author manuscript, 658 KB

Handle.net

Persistent link

Cite this

@article{9e84bb3b47a14066ab5ad842977d8cb1,

title = "Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000",

abstract = "BACKGROUND: People with head and neck cancer have higher comorbidity levels but it remains unclear if pretreatment comorbidity is an independent prognosticator in head and neck cancer.METHODS: Survival analyses were performed using data from participants in a UK multicentre cohort study with cancers of the oral cavity (n = 668), oropharynx (n = 1074), and larynx (n = 530). Survival analyses were incrementally adjusted for age, sex, marital status, income, education, stage, alcohol, and smoking.RESULTS: After adjusting for demographic, clinical, and behavioral confounders, higher baseline comorbidity was associated with reduced overall survival (mild comorbidity HR = 1.4, 95% CI = 1.1, 1.7; moderate comorbidity HR = 1.7, 95% CI = 1.3, 2.2; severe comorbidity HR = 2.8, 95% CI = 1.9, 4.; P-trend<.001).CONCLUSIONS: Our findings suggest that comorbidity is an independent prognosticator for overall survival in head and neck cancer. Comorbid illnesses should be considered in the assessment and treatment planning of people with head and neck cancer.",

keywords = "comorbidity, ACE 27, survival, head and neck cancer, human papillomavirus",

author = "Sarah Schimansky and Samantha Lang and Rhona Beynon and Christopher Penfold and Amy Davies and Andrea Waylen and Steve Thomas and Miranda Pring and Michael Pawlita and Tim Waterboer and Andy Ness",

year = "2019",

month = apr,

day = "1",

doi = "10.1002/hed.25543",

language = "English",

volume = "41",

pages = "1053--1062",

journal = "Head and Neck",

issn = "1043-3074",

publisher = "John Wiley & Sons, Inc",

number = "4",

}

TY - JOUR

T1 - Association between comorbidity and survival in head and neck cancer

T2 - Results from Head and Neck 5000

AU - Schimansky, Sarah

AU - Lang, Samantha

AU - Beynon, Rhona

AU - Penfold, Christopher

AU - Davies, Amy

AU - Waylen, Andrea

AU - Thomas, Steve

AU - Pring, Miranda

AU - Pawlita, Michael

AU - Waterboer, Tim

AU - Ness, Andy

PY - 2019/4/1

Y1 - 2019/4/1

N2 - BACKGROUND: People with head and neck cancer have higher comorbidity levels but it remains unclear if pretreatment comorbidity is an independent prognosticator in head and neck cancer.METHODS: Survival analyses were performed using data from participants in a UK multicentre cohort study with cancers of the oral cavity (n = 668), oropharynx (n = 1074), and larynx (n = 530). Survival analyses were incrementally adjusted for age, sex, marital status, income, education, stage, alcohol, and smoking.RESULTS: After adjusting for demographic, clinical, and behavioral confounders, higher baseline comorbidity was associated with reduced overall survival (mild comorbidity HR = 1.4, 95% CI = 1.1, 1.7; moderate comorbidity HR = 1.7, 95% CI = 1.3, 2.2; severe comorbidity HR = 2.8, 95% CI = 1.9, 4.; P-trend<.001).CONCLUSIONS: Our findings suggest that comorbidity is an independent prognosticator for overall survival in head and neck cancer. Comorbid illnesses should be considered in the assessment and treatment planning of people with head and neck cancer.

AB - BACKGROUND: People with head and neck cancer have higher comorbidity levels but it remains unclear if pretreatment comorbidity is an independent prognosticator in head and neck cancer.METHODS: Survival analyses were performed using data from participants in a UK multicentre cohort study with cancers of the oral cavity (n = 668), oropharynx (n = 1074), and larynx (n = 530). Survival analyses were incrementally adjusted for age, sex, marital status, income, education, stage, alcohol, and smoking.RESULTS: After adjusting for demographic, clinical, and behavioral confounders, higher baseline comorbidity was associated with reduced overall survival (mild comorbidity HR = 1.4, 95% CI = 1.1, 1.7; moderate comorbidity HR = 1.7, 95% CI = 1.3, 2.2; severe comorbidity HR = 2.8, 95% CI = 1.9, 4.; P-trend<.001).CONCLUSIONS: Our findings suggest that comorbidity is an independent prognosticator for overall survival in head and neck cancer. Comorbid illnesses should be considered in the assessment and treatment planning of people with head and neck cancer.

KW - comorbidity

KW - ACE 27

KW - survival

KW - head and neck cancer

KW - human papillomavirus

UR - http://www.scopus.com/inward/record.url?scp=85058692631&partnerID=8YFLogxK

U2 - 10.1002/hed.25543

DO - 10.1002/hed.25543

M3 - Article (Academic Journal)

C2 - 30549147

AN - SCOPUS:85058692631

SN - 1043-3074

VL - 41

SP - 1053

EP - 1062

JO - Head and Neck

JF - Head and Neck

IS - 4

ER -

Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000

Abstract

Research Groups and Themes

Keywords

UN SDGs

Access to Document

Handle.net

Other files and links

Fingerprint

NIHR BRC Nutrition

Dr Miranda Pring

Cite this

Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000

Abstract

Research Groups and Themes

Keywords

UN SDGs

Access to Document

Handle.net

Other files and links

Fingerprint

Projects

NIHR BRC Nutrition

Profiles

Dr Miranda Pring

Cite this